Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Show more...
FAQ
Silk Road Medical 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Boerse Muenchen 交易所,Silk Road Medical 的股票以代號 2OW.MU 進行交易。
Silk Road Medical 有多少名員工?▼
截至 July 11, 2026,公司共有 474 名員工。
Silk Road Medical 位於哪個產業?▼
Silk Road Medical從事於Manufacturing產業。
Silk Road Medical 何時完成拆股?▼
Silk Road Medical 最近沒有進行任何拆股。
Silk Road Medical 的總部在哪裡?▼
Silk Road Medical 的總部位於 美國 的 Sunnyvale。